Mexico-Based Platform
CELLMEX is building its principal laboratory, clinical and administrative platform in Mexico.
For Clinics & Hospitals
Institutional collaboration in regenerative medicine.
CELLMEX works with clinics, hospitals, specialist physicians, research centres and healthcare systems interested in evaluating regenerative medicine programmes, laboratory support, scientific protocols, patient referrals and institutional collaboration.
Institutional Overview
A professional pathway for healthcare institutions
CELLMEX is developing a regenerative medicine platform intended to support qualified clinics, hospitals and healthcare systems seeking a more structured approach to cellular and cell-free biological technologies.
Institutional collaboration may involve patient referrals, physician consultation, programme development, scientific documentation, laboratory support, professional training or formal research cooperation.
CELLMEX does not assume that one commercial or clinical model is suitable for every institution. The proposed relationship must reflect the facility's medical specialties, licensed professionals, patient population, infrastructure, jurisdiction and intended scope.
Mexico is treated as the primary institutional market. Expansion into the rest of Latin America, including Brazil, requires separate legal, professional, operational and regulatory review.
Why Institutions Work with CELLMEX
More than access to a single treatment
Multiple Technologies
The platform includes MSCs, extracellular vesicles, exosome-related technologies, secretome, conditioned media and advanced cellular research.
Regional Collaboration
Institutional relationships may be developed throughout Latin America on a country-specific basis.
Physician Support
Clinical collaboration may include protocol review, patient eligibility guidance and professional consultation.
Laboratory Perspective
CELLMEX approaches regenerative medicine through biological identity, process control, scientific evidence and responsible clinical translation.
Multilingual Development
Spanish-language regional services are complemented by a separate Portuguese-language strategy for Brazil.
Clinics & Hospitals in Mexico
Institutional collaboration within Mexico
Mexican clinics and hospitals form the primary institutional focus of the CELLMEX development model.
Patient Referral Collaboration
Clinics and hospitals may refer selected patients for medical review and possible treatment at an authorised CELLMEX clinical location.
- Structured medical-record submission
- Physician-to-physician case discussion
- Patient eligibility review
- Treatment coordination
- Follow-up communication
Programme Development
CELLMEX may discuss the development of a regenerative medicine programme within an appropriately qualified institution.
- Clinical scope and service design
- Physician and nursing responsibilities
- Patient-selection procedures
- Documentation and informed consent
- Follow-up and adverse-event procedures
Laboratory and Biological Support
Institutional enquiries may concern available cellular or cell-free platforms, laboratory capabilities and technical documentation.
- Product and technology descriptions
- Handling and storage requirements
- Available quality documentation
- Laboratory consultation
- Research and analytical collaboration
Physician Education and Training
Professional education may be developed for approved institutional partners.
- Scientific background
- Patient-selection considerations
- Product handling
- Clinical workflow
- Follow-up and documentation
Latin American Institutions
Regional collaboration beyond Mexico
CELLMEX may evaluate institutional relationships throughout Latin America, but each country requires its own clinical, legal, regulatory and commercial assessment.
Referral and Clinical Networks
Potential collaboration with specialist physicians, private clinics and hospitals for patient referral, case review and professional education.
Colombia and Regional Partners
Potential institutional, research and physician relationships subject to local requirements and product-specific review.
Peru and Neighbouring Markets
Potential referral, research and specialist-clinic collaboration following jurisdiction-specific assessment.
Institutional Development
Potential academic, hospital and specialist collaborations requiring separate regulatory and operational planning.
International Patient Coordination
Potential referral pathways for eligible patients travelling to Mexico for evaluation or treatment.
Universities and Laboratories
Scientific cooperation may include in-vitro, ex-vivo, analytical and translational research.
Brazil
A separate Portuguese-language institutional strategy
Brazil should not be treated as a simple extension of the Spanish-speaking Latin American strategy.
Institutional development in Brazil requires Portuguese-language communication, local professional relationships, Brazil-specific regulatory analysis and separate commercial planning.
Potential initial relationships may include research institutions, specialist physicians, private hospitals, biotechnology laboratories and academic medical centres.
Any proposed clinical supply, patient programme, product importation, professional training or research collaboration must be reviewed under the requirements applicable in Brazil.
Partnership Models
Potential forms of institutional collaboration
Patient Referral Agreement
Structured referral and clinical communication for eligible patients evaluated by CELLMEX.
Institutional Treatment Programme
Development of a defined regenerative medicine service within an appropriately qualified clinic or hospital.
Physician Education Programme
Scientific, technical and clinical education for institutional medical personnel.
Laboratory Collaboration
Research, analytical, processing or technical cooperation between qualified laboratories.
Research Collaboration
Joint in-vitro, ex-vivo or translational research under a defined scientific and contractual framework.
Regional Strategic Partnership
Controlled market development involving an institution with suitable clinical, scientific and operational capabilities.
Institutional Review Process
From enquiry to formal collaboration
Submit Institutional Profile
Provide the institution's identity, location, licences, specialties and responsible contacts.
Define the Objective
Identify whether the request concerns referrals, protocols, treatment programmes, research or laboratory support.
Professional Review
CELLMEX reviews the medical, scientific, operational and jurisdictional requirements.
Preliminary Proposal
Where appropriate, the parties define scope, responsibilities, documentation and next steps.
Formal Agreement
Collaboration proceeds only after approval of the required legal, professional and operational documentation.
Information Required
What should an enquiring institution provide?
Institutional Information
- Legal name and country
- Full facility address
- Clinic, hospital or research-centre type
- Principal medical specialties
- Website and institutional profile
- Responsible administrative contact
Medical and Professional Information
- Medical director or responsible physician
- Professional licence information
- Relevant specialist physicians
- Clinical and nursing capabilities
- Emergency and patient-monitoring resources
- Existing regenerative medicine experience
Proposed Collaboration
- Technology or treatment of interest
- Intended clinical or research use
- Estimated patient or project volume
- Proposed start date
- Required protocols or documentation
- Expected role of CELLMEX
Facility and Logistics
- Treatment rooms and clinical infrastructure
- Storage and temperature-control capabilities
- Laboratory or pharmacy support
- Importation capability, where applicable
- Internal quality systems
- Adverse-event and follow-up procedures
Institutional FAQ
Frequently asked questions from clinics and hospitals
Can our clinic refer patients to CELLMEX?
Yes. A referral relationship may be considered after verification of the referring institution and responsible physician.
Patient acceptance remains subject to medical review and does not occur automatically.
Can CELLMEX establish a programme inside our hospital?
Potentially. The proposed programme would require assessment of the institution's physicians, facilities, jurisdiction, clinical capabilities, documentation systems and intended technology.
Does CELLMEX supply cellular or cell-free products directly?
Product or biological-platform supply should not be assumed. Availability depends on the institution, intended use, jurisdiction, storage capability, professional oversight and applicable requirements.
Can our physicians request CELLMEX protocols?
Yes. Protocol and technical-document requests may be reviewed after professional and institutional verification.
Does CELLMEX provide staff training?
Professional education may be considered for approved partners. Training does not replace medical licensing, specialty competence or institutional credentialing.
Can our institution conduct research with CELLMEX?
Yes. Research proposals should define the scientific objective, methods, biological materials, responsibilities, funding, intellectual property and required approvals.
Does a Mexican collaboration permit operation in another Latin American country?
No. Each country must be reviewed separately. A Mexican agreement or operational model does not automatically authorise clinical use, importation, promotion or distribution in another jurisdiction.
Can Brazilian hospitals submit enquiries in Portuguese?
Yes. Brazilian institutions may submit enquiries in Portuguese. Formal implementation should use Portuguese-language clinical, technical and contractual documentation.
Does CELLMEX offer territorial exclusivity?
Exclusivity should not be assumed. Any territorial, institutional, distribution or representation rights require a separate written agreement and legal review.
What happens after we submit an institutional enquiry?
CELLMEX will review the institutional profile, objective, responsible professionals, jurisdiction and proposed technology.
If the enquiry is suitable for further review, CELLMEX may request additional documentation or arrange an introductory discussion.
Important institutional qualification
Submission of an enquiry does not establish a partnership, approve a clinical programme, confirm product supply or authorise the use of CELLMEX technologies.
All arrangements remain subject to professional verification, legal documentation, jurisdictional review, internal approval and definition of the parties' respective responsibilities.
Clinical and scientific information must not be converted into unsupported patient advertising or treatment claims.
Institutional Enquiry
Request a clinic or hospital collaboration review
Complete the form below with sufficient institutional information for an initial review.
General Email
info@cellmex.comTelephone
+52 322 308 0021Location
Marina Vallarta
Puerto Vallarta, Jalisco
Mexico
Regional Enquiries
Mexico · Latin America · Brazil